FindTrial
Sign In

A randomized controlled trial for comparing the effect and outcomes with different embolic agent: Absolute ethanol, Onyx and n-BCA in the treatment of AVM

A randomized controlled trial for comparing the effect and outcomes with different embolic agent: Absolute ethanol, Onyx and n-BCA in the treatment of AVM

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800017616
Enrollment
Unknown
Registered
2018-08-06
Start date
2018-08-06
Completion date
Unknown
Last updated
2018-08-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

arteriovenous malformations

Interventions

Ethanol group:Embolization with ethanol
Onyx group:Embolization with Onyx
n-BCA group:Embolization with n-BCA

Sponsors

Shanghai 9th People's Hospital, Shanghai Jiaotong University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Arteriovenous malformations in head and neck region, without involvement of bone; 2) Schobinger Stage II-III; 3) Patient agrees to participate in the clinical trial.

Exclusion criteria

Exclusion criteria: 1) Any involvement of bone, detected by enhanced-CT; 2) Dysfunction of heart or pulmonary, detected by echocardiography; 3) Patient refuses to participate.

Design outcomes

Primary

MeasureTime frame
Radiological manisfestations;Clinical manisfestations;complications;Other conditions;—

Countries

China

Contacts

Public ContactXin-dong Fan

Shanghai 9th People's Hospital, Shanghai Jiaotong University School of Medicine

fanxindong@aliyun.com+86 021-2965666

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026